LVS Stock Analysis: Las Vegas Sands | NYSE
Resorts & Casinos | NYSE, USA | Market Cap: 23.382m USD | 12M Return: -28.7% | US5178341070 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 213M
EPS Trend: 82.8%
Qual. Beats: -1
Rev. Trend: 90.1%
Qual. Beats: -1
Warnings
Tailwinds
No distinct edge detected
Seasonality 11.7 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Las Vegas Sands Corp. (LVS) is a major operator of integrated resorts, with all of its operations concentrated in Macao and Singapore. Its Macao portfolio includes The Venetian Macao, The Londoner Macao, The Parisian Macao, The Plaza Macao and Four Seasons Hotel Macao, and The Sands Macao, while in Singapore it operates Marina Bay Sands. Founded in 1988 and headquartered in Las Vegas, Nevada, the company is classified in the Consumer Discretionary sector under the Casinos & Gaming sub-industry.
LVSs integrated resorts combine gaming with hotels, entertainment venues, retail malls, convention and exhibition facilities, and celebrity chef restaurants, generating revenue across both gaming and non-gaming segments. This integrated resort model is the dominant business structure in Asian gaming markets, allowing operators to capture spending from a broader base of leisure and business travelers rather than gaming customers alone.
Macao is one of the largest gaming markets in the world, and Singapores casino sector operates under a limited-licence framework, with Marina Bay Sands being one of only two licensed integrated resorts in the country.
- Macao mass-market gaming revenue recovery lifts consolidated EBITDA
- Marina Bay Sands Singapore posts record margins on tourism rebound
- China consumer slowdown and travel restrictions pressure Macao visitation
- Capital returns through dividend and buyback program accelerate
| Net Income: 1.75b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.14 > 0.02 and ΔFCF/TA 11.12 > 1.0 |
| NWC/Revenue: -0.10% < 20% (prev 6.56%; Δ -6.66% < -1%) |
| CFO/TA 0.19 > 3% & CFO 3.74b > Net Income 1.75b |
| Net Debt (11.9b) to EBITDA (4.62b): 2.57 < 3 |
| Current Ratio: 1.00 > 1.5 & < 3 |
| Outstanding Shares: last quarter (663.0m) vs 12m ago -4.74% < -2% |
| Gross Margin: 50.89% > 18% (prev 49.38%; Δ 1.51% > 0.5%) |
| Asset Turnover: 65.71% > 50% (prev 53.16%; Δ 12.55% > 0%) |
| Interest Coverage Ratio: 4.10 > 6 (EBIT TTM 3.10b / Interest Expense TTM 755.0m) |
| A: -0.00 (Total Current Assets 4.30b - Total Current Liabilities 4.31b) / Total Assets 19.9b |
| B: 0.25 (Retained Earnings 4.90b / Total Assets 19.9b) |
| C: 0.15 (EBIT TTM 3.10b / Avg Total Assets 20.9b) |
| D: 0.03 (Book Value of Equity 581.0m / Total Liabilities 19.0b) |
| Altman-Z'' = 1.83 = BBB |
| DSRI: 0.94 (Receivables 591.0m/533.0m, Revenue 13.7b/11.6b) |
| GMI: 0.97 (GM 49.38% / 50.89%) |
| AQI: 1.76 (AQ_t 0.21 / AQ_t-1 0.12) |
| SGI: 1.18 (Revenue 13.7b / 11.6b) |
| TATA: -0.10 (NI 1.75b - CFO 3.74b) / TA 19.9b) |
| Beneish M = -2.54 (Cap -4..+1) = A |
As of October 10, 2026, the stock is trading at USD 36.17 with a total of 4,128,097 shares traded. Over the past week, the price has changed by -0.17%, over one month by -16.52%, over three months by -21.63% and over the past year by -28.74%.
Current recommended Stop Loss: 34.90 (which is 3.5% or 1.3 ATR below the current price).
Las Vegas Sands has received a consensus analysts rating of 4.19. Therefore, it is recommended to buy LVS.
- StrongBuy: 11
- Buy: 3
- Hold: 7
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 58.8 | 62.4% |
P/E Trailing = 14.0467
P/E Forward = 11.2108
P/S = 1.7044
P/B = 44.2577
P/EG = 0.8432
Revenue TTM = 13.7b USD
EBIT TTM = 3.10b USD
EBITDA TTM = 4.62b USD
Long Term Debt = 13.7b USD (from longTermDebt, last quarter)
Short Term Debt = 1.57b USD (from shortTermDebt, last quarter)
Debt = 15.3b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 11.9b USD (calculated: Debt 15.3b - CCE 3.38b)
Enterprise Value = 35.3b USD (23.4b + Debt 15.3b - CCE 3.38b)
Interest Coverage Ratio = 4.10 (Ebit TTM 3.10b / Interest Expense TTM 755.0m)
EV/FCF = 12.65x (Enterprise Value 35.3b / FCF TTM 2.79b)
FCF Yield = 7.91% (FCF TTM 2.79b / Enterprise Value 35.3b)
FCF Margin = 20.32% (FCF TTM 2.79b / Revenue TTM 13.7b)
Net Margin = 12.79% (Net Income TTM 1.75b / Revenue TTM 13.7b)
Gross Margin = 50.89% ((Revenue TTM 13.7b - Cost of Revenue TTM 6.74b) / Revenue TTM)
Gross Margin QoQ = 57.23% (prev 48.79%)
Tobins Q-Ratio = 1.77 (Enterprise Value 35.3b / Total Assets 19.9b)
Interest Expense / Debt = 4.95% (Interest Expense 755.0m / Debt 15.3b)
Taxrate = 9.09% (213.0m / 2.34b)
NOPAT = 2.82b (EBIT 3.10b * (1 - 9.09%))
Current Ratio = 1.00 (Total Current Assets 4.30b / Total Current Liabilities 4.31b)
Debt / Equity = 26.27 (Debt 15.3b / totalStockholderEquity, last quarter 581.0m)
Debt / EBITDA = 2.57 (Net Debt 11.9b / EBITDA 4.62b)
Debt / FCF = 4.26 (Net Debt 11.9b / FCF TTM 2.79b)
Total Stockholder Equity = 1.24b (last 4 quarters mean from totalStockholderEquity)
RoA = 8.40% (Net Income 1.75b / Total Assets 19.9b)
RoE = 142.0% (Net Income TTM 1.75b / Total Stockholder Equity 1.24b)
RoCE = 20.74% (EBIT 3.10b / Capital Employed (Equity 1.24b + L.T.Debt 13.7b))
RoIC = 17.08% (NOPAT 2.82b / Invested Capital 16.5b)
WACC = 7.19% (E(23.4b)/V(38.6b) * Re(8.95%) + D(15.3b)/V(38.6b) * Rd(4.95%) * (1-Tc(0.09)))
Discount Rate = 8.95% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -98.33 | Cagr: -5.44%
[DCF] Terminal Value 77.97% ; FCFF base≈1.92b ; Y1≈2.21b ; Y5≈3.25b
[DCF] Fair Price = 57.08 (EV 48.9b - Net Debt 11.9b = Equity 37.0b / Shares 647.7m; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 82.84 | EPS CAGR: 30.58% | SUE: -1.53 | # QB: -1
Revenue Correlation: 90.14 | Revenue CAGR: 13.68% | SUE: -0.92 | # QB: -1
EPS current Quarter (2026-09-30): EPS=0.74 | Chg30d=-0.92% | Revisions=+0% | Analysts=14
EPS current Year (2026-12-31): EPS=3.08 | Chg30d=-0.31% | Revisions=+25% | GrowthEPS=+2.4% | GrowthRev=+5.9%
EPS next Year (2027-12-31): EPS=3.50 | Chg30d=-0.47% | Revisions=-40% | GrowthEPS=+13.7% | GrowthRev=+5.5%
[Analyst] Revisions Ratio: -12% (up=2, down=3)